RVTY raises margin guidance on AI-driven demand and cost initiatives
RVTY cites AI-driven demand for high-content screening and software innovation, plus robust diagnostics and reproductive health growth. It also says a tuck-in reagents acquisition supports the reagents business, and raises margin guidance on execution and cost initiatives.
A tuck-in acquisition is supporting the reagents business, while AI-driven demand is lifting high-content screening and software innovation. Diagnostics and reproductive health segments are also showing robust growth, and margin guidance has been raised on strong execution and cost initiatives. Confidence remains high for…